$RAFA News Out SANDY, UT--(Marketwired - Apr 8, 2013) -

New Post Public Reply Private Reply Replies (0) Message Board
jstops

[b]$RAFA[/b] News Out SANDY, UT--(Marketwired - Apr 8, 2013) - Rafarma Pharmaceuticals, Inc. (PINKSHEETS: RAFA), a Russia-based multi-product pharmaceutical company producing generic antibiotics and specialty pharmaceuticals in addition to its own line of proprietary products, today announces that ZAO "Rafarma" has registered (MHH) CEFTRIAXONE, a third-generation cephalosporin antibiotic, as a medication under international unpatented label.

CEFTRIAXONE is most often used in combination for the treatment of pneumonia, bacterial meningitis, gonorrhea, and in pediatrics for the prevention of sepsis. Market capacity of CEFTRIAXONE in the Russian Federation in 2012 was USD $85.7 million dollars, an increase of 20% compared to its capacity in 2011.

Dave Anderson, CEO of Rafarma Pharmaceuticals, said, "Registering this product is complementary to our goal of producing high-quality pharmaceutical products. Rafarma is positioned to meet rising market demand for CEFTRIAXONE utilizing our state-of-the-art research facility and staff as we continue efforts to expand our product portfolio."

"I'd also like to clarify that Rafarma's earlier announcement reporting its status as 1 of 4 National Strategic Pharmaceutical Suppliers to the Russian Federation in no way limits our ability to produce and manufacture products for qualified buyers globally," added Mr. Anderson. "We will offer CEFTRIAXONE, as well as all other products we produce, to the international market."

About Rafarma Pharmaceuticals, Inc.

Operating from a new 270,000 square-foot state-of-the-art manufacturing and distribution facility in Russia, Rafarma Pharmaceuticals produces generic antibiotics and specialty pharmaceuticals in addition to its own line of proprietary products that are approved by the Ministry of Health of Russian Federation. For the last three years the Russian Government has been highly focused on bolstering the development of nation's domestic pharmaceutical industry. Rafarma Pharmaceuticals' mission is to work with the auspices of aggressive federal initiatives to fast-track the modernization of Russia's pharmaceutical industry.

To view additional information on Rafarma Pharmaceuticals, visit: www.rafarma.com

To like our Facebook page or follow us on Twitter for company updates and industry related news, visit: www.facebook.com/Rafarmainfo and www.twitter.com/Rafarmainfo

Scroll down for more posts ▼

Top 10 Most Recent News Articles

First-Time Clermont Homebuyers Face Unexpected Hurdles

Updated Category News Views 52

Welcome to the Wild Ride of Buying a Home! When folks step into the homebuying ring, especially in places like Clermont, Florida, they often don't realize how chaotic things can get. It's like being thrown into a boxing match without gloves. Brandie Mathison-Klein from the Mathison-Klein Group shines a light on this in a HelloNation piece, spilling the beans on what...

Continue Reading
Hybrid Bonding Market Shooting to $2.45 Billion by 2033

Updated Category News Views 68

Hybrid Bonding: The Future of Semiconductor Interconnects? Mark these words: Hybrid bonding isn't just another tech trend—it’s morphing into a billion-dollar juggernaut, my friend. With the latest numbers from MarketsandMarkets™, we see a potential leap from USD 0.38 billion in 2026 to a staggering USD 2.45 billion by 2033. We'll be seeing an eye-popping CAGR of...

Continue Reading
Pine AI Unveils AI Studio & Real-World Call Feature

Updated Category News Views 37

Push Your Expectations: Pine AI Takes the Stage Here's a twist in tech worth a double take. Pine AI is shaking up the AI world with a brash blend of video genius and actual chat capabilities. Somehow, merely weeks after setting the tech scene ablaze with its AI-focused computer, it's already rolling out new applications faster than hotcakes on a skillet. But let’s chew...

Continue Reading
Sasol Names Stanley Subramoney as Audit Chair

Updated Category News Views 183

Shifting Sands at Sasol's Audit Helm Ah, the boardroom dance continues. Sasol has just announced, loud and clear from Johannesburg, that Mr. Stanley Subramoney is stepping up as the new Chairman of their Audit Committee. This is no small shuffle in the deck. When it comes to keeping the books in check at big players like Sasol, you need a top-tier audit leader. Ain't no...

Continue Reading
Timken Maintains Robust Dividend Streak in 2026

Updated Category News Views 76

Timken Keeps Dividend Train Rolling You want to talk consistency? Timken Company just declared its quarterly dividend like clockwork. As a stockholder, that might just be your morning coffee fix before anything else. Notably, Timken's been on the NYSE since 1922, having cranked out 418 consecutive dividend payouts. That's like your grandpa never missing a Sunday golf...

Continue Reading
IM Cannabis's Third Quarter Financial Jolt

Updated Category News Views 91

IM Cannabis Takes a Hit, But Seeks New Angles Diving into IM Cannabis's (NASDAQ: IMCC) latest financial splash is like reading a weathered old map of the stock market. The third quarter of 2026 wasn't kind to this little cannabis outfit. Revenues have nosedived to C$1.65 million from last year's C$5.08 million. It's not just the typical bad quarter blues; it's a solid...

Continue Reading
TIGR Investors Eye Class Action Amid Legal Woes

Updated Category News Views 69

A Legal Storm Brews Over UP Fintech When it rains, it pours, and for UP Fintech Holding Limited, the sky's looking pretty stormy. Investors who jumped on the NASDAQ:TIGR bandwagon between April 2024 and June 2026 are finding themselves at the center of a nasty legal maelstrom. The allegations? Well, they're explosive, hinting at a pattern of unlicensed cross-border...

Continue Reading
CVRx Faces Legal Storm: Investors Grapple with Fallout

Updated Category News Views 45

CVRx in the Crosshairs: Legal and Operational Woes There's a storm brewing over at CVRx, Inc. (NASDAQ: CVRX), and it's pulling investors down a hell of a financial rabbit hole. You might think you're in the clear with a company like CVRx that boasts approved devices, but think again. Recent revelations have shown that even those with FDA stamps aren't immune to the...

Continue Reading
Finding the Right Auto Insurance: What to Consider

Updated Category News Views 79

Understanding the Basics of Auto Insurance Coverage Now, you might think the state knows best when it sets those minimum auto insurance requirements. But let's not kid ourselves—skimping on coverage can leave you high and dry if things go south on the road. That's where an expert voice like Corey Frazer's comes in, laying out why those limits often fall short. Minimum...

Continue Reading
Class Action Looms Over The Chemours Company

Updated Category News Views 126

Chemours Under Fire: What’s Happening? Here we are, in the thick of a legal storm surrounding The Chemours Company. A class-action lawsuit is underway, and it’s painting the company in a rather unflattering light. Now, if you snagged some of that NYSE:CC action between February 20, 2026, and August 4, 2026, there's a chance you’re caught in the crossfire. Per the...

Continue Reading

Top 5 Most Recently Viewed Articles

Cango Inc. Reports Impressive Bitcoin Production Growth

Updated Category News Views 107

Cango Inc. Performs Exceptionally in Bitcoin Mining Operations Cango Inc. has seen remarkable progress in its Bitcoin mining endeavors, as showcased by its recent production report. The company operates using a well-structured strategy, which has proven successful in driving growth within the cryptocurrency market. Key Metrics to Note The September report illustrates the...

Continue Reading
BWXT Awarded Deconversion Contract by U.S. DOE for HALEU

Updated Category News Views 162

BWXT's Achievement in Nuclear Fuel Deconversion Rich in innovation and commitment to nuclear solutions, BWX Technologies, Inc. (NYSE: BWXT) has recently announced a significant achievement. Their Nuclear Fuel Services, Inc. (NFS) division has been selected by the U.S. Department of Energy (DOE) as part of a prominent initiative. This recognition places BWXT at the...

Continue Reading
SEALSQ Showcases Quantum-Resistant Solutions at Quantum Days

Updated Category News Views 299

SEALSQ Showcases Quantum-Resistant Solutions at Quantum Days During a recent event, SEALSQ Corp (NASDAQ: LAES), a leader in semiconductor and post-quantum technology, demonstrated its commitment to cutting-edge security solutions. The event showcased live demonstrations highlighting the effectiveness of post-quantum cryptography (PQC) through their implementation of two...

Continue Reading
Ultragenyx Pharmaceutical Grants Stock Units to New Officers

Updated Category News Views 152

Ultragenyx Pharmaceutical Welcomes New Team Members Novato, California - Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a dedicated biopharmaceutical entity, proudly reports the issuance of 20,820 restricted stock units to 13 newly hired non-executive officers as part of their employment inducement initiative. This decision, approved by the company's compensation...

Continue Reading
Alto Neuroscience Faces Class Action Amid Allegations of Fraud

Updated Category News Views 134

Alto Neuroscience Faces Class Action Lawsuit for Securities Issues In recent developments, Alto Neuroscience, Inc. finds itself at the center of a class action lawsuit alleging securities fraud, with significant implications for its investors. The lawsuit, spearheaded by prominent legal firm Levi & Korsinsky, LLP, aims to secure compensation for stockholders negatively...

Continue Reading